Indications and uses
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
■ do not crush, chew, or break caplet ■ take with a full glass of water ■ adults and children 12 years of age and over: take 1 caplet every 4 hours with a full glass of water while symptoms persist. Do not exceed 6 caplets in 24 hours. ■ children under 12 years of age: do not use
■ store between 20-25°C (68-77°F)
Guaifenesin 400 mg
Expectorant
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make
coughs more productive
Warnings
■ for children under 12 years of age
■ persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
■ cough accompanied by too much phlegm (mucus)
■ cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a
serious illness.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
■ do not crush, chew, or break caplet ■ take with a full glass of water
■ adults and children 12 years of age and over: take 1 caplet every 4 hours with a full glass of water while symptoms
persist. Do not exceed 6 caplets in 24 hours.
■ children under 12 years of age: do not use
■ store between 20-25°C (68-77°F)
Colloidal silicon dioxide, magnesium stearate, maltodextrin, microcrystalline cellulose, polyvinyl pyrrolidone, sodium starch
glycolate, stearic acid
1-888-333-9792
Mucus Relief
Guaifenesin 400mg
50 Tablets
| Class | Version | Type | Effective |
|---|---|---|---|
| GUAIFENESIN Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20211129 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68210-4102-1 | 2026-01-29 | C162847 | 48780-1 | f386c649-d153-0266-e053-dadaa90a7c1a | Guaifenesin 400mg |
| 68210-4102-2 | 2026-01-29 | C162847 | 48780-1 | f386c649-d153-0266-e053-dadaa90a7c1a | Guaifenesin 400mg |
| 68210-4102-5 | 2026-01-29 | C162847 | 48780-1 | f386c649-d153-0266-e053-dadaa90a7c1a | Guaifenesin 400mg |
| 68210-4102-1 | 2023-12-07 | C162847 | 48780-1 | f386c649-d153-0266-e053-dadaa90a7c1a | Guaifenesin 400mg |
| 68210-4102-2 | 2023-12-07 | C162847 | 48780-1 | f386c649-d153-0266-e053-dadaa90a7c1a | Guaifenesin 400mg |
| 68210-4102-5 | 2023-12-07 | C162847 | 48780-1 | f386c649-d153-0266-e053-dadaa90a7c1a | Guaifenesin 400mg |
| 68210-4102-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-d153-0266-e053-dadaa90a7c1a | Guaifenesin 400mg |
| 68210-4102-2 | 2023-01-30 | C162847 | 48780-1 | f386c649-d153-0266-e053-dadaa90a7c1a | Guaifenesin 400mg |
| 68210-4102-5 | 2023-01-30 | C162847 | 48780-1 | f386c649-d153-0266-e053-dadaa90a7c1a | Guaifenesin 400mg |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68210-4102-1 | MUCUS RELIEF | 200 in 1 BOTTLE | TABLET | 200 | 6 | |
| 68210-4102-2 | MUCUS RELIEF | 50 in 1 PACKAGE | TABLET | 50 | 6 | |
| 68210-4102-5 | MUCUS RELIEF | 150 in 1 BOTTLE | TABLET | 150 | 6 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68210-4102 | MUCUS RELIEF (GUAIFENESIN) TABLET [SPIRIT PHARMACEUTICALS LLC] | 6 | Legacy NDC, 3 package rows | 20241215_d2ab3a1d-6b47-4b4e-b47a-eee79eac2a1e.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68210-4102 | 68210-4102-2, 68210-4102-1, 68210-4102-5 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| POVIDONE K30 | U725QWY32X | IACT |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | 5856J3G2A2 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| GUAIFENESIN | 495W7451VQ | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 292d5dc6-918c-32d8-e063-6294a90a1494 | d2ab3a1d-6b47-4b4e-b47a-eee79eac2a1e | 2024-12-13 | Warnings | 292d5dc6-918c-32d8-e063-6294a90a1494 d2ab3a1d-6b47-4b4e-b47a-eee79eac2a1e |
Adverse event summaries are temporarily unavailable. Other product information remains available.